Lv2
110 积分 2022-09-19 加入
RECENT ADVANCES IN THE DISCOVERY OF CYCLIN-DEPENDENT KINASE 2 (CDK2) SELECTIVE INHIBITORS
13天前
已完结
Structural and energetic insights into the selective inhibition of PKMYT1 against WEE1
2个月前
已完结
Atropisomeric 4-Phenyl-4H-1,2,4-triazoles as Selective Glycine Transporter 1 Inhibitors
2个月前
已完结
Atropisomerism Observed in Galactose-Based Monosaccharide Inhibitors of Galectin-3 Comprising 2-Methyl-4-phenyl-2,4-dihydro-3H-1,2,4-triazole-3-thione
2个月前
已完结
Atropisomerism by Design: Discovery of a Selective and Stable Phosphoinositide 3-Kinase (PI3K) β Inhibitor
2个月前
已完结
Structure-Based Drug Design of 2-Amino-[1,1′-biphenyl]-3-carboxamide Derivatives as Selective PKMYT1 Inhibitors for the Treatment of CCNE1-Amplified Breast Cancer
2个月前
已完结
Research Progress on Small-molecule Inhibitors of Protein Arginine Methyltransferase 5 (PRMT5) for Treating Cancer
3个月前
已完结
RECENT ADVANCES IN TARGETING THE PRMT5/MTA COMPLEX
3个月前
已完结
New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives
3个月前
已完结
A novel dual ATM/DNA-PK inhibitor, XRD-0394, potently radiosensitizes and potentiates PARP and topoisomerase I inhibitors
4个月前
已完结
皖公网安备34019202002308
